16-50675881-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_182854.4(SNX20):c.171G>A(p.Thr57=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00267 in 1,612,116 control chromosomes in the GnomAD database, including 106 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.015 ( 59 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 47 hom. )
Consequence
SNX20
NM_182854.4 synonymous
NM_182854.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.24
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 16-50675881-C-T is Benign according to our data. Variant chr16-50675881-C-T is described in ClinVar as [Benign]. Clinvar id is 777015.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.24 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0147 (2235/152270) while in subpopulation AFR AF= 0.051 (2121/41558). AF 95% confidence interval is 0.0492. There are 59 homozygotes in gnomad4. There are 1024 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 59 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SNX20 | NM_182854.4 | c.171G>A | p.Thr57= | synonymous_variant | 3/4 | ENST00000330943.9 | |
SNX20 | NM_153337.3 | c.171G>A | p.Thr57= | synonymous_variant | 3/4 | ||
SNX20 | NM_001144972.2 | c.171G>A | p.Thr57= | synonymous_variant | 3/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SNX20 | ENST00000330943.9 | c.171G>A | p.Thr57= | synonymous_variant | 3/4 | 1 | NM_182854.4 | P1 | |
SNX20 | ENST00000423026.6 | c.171G>A | p.Thr57= | synonymous_variant | 3/4 | 1 | |||
SNX20 | ENST00000568993.5 | c.171G>A | p.Thr57= | synonymous_variant, NMD_transcript_variant | 3/5 | 1 | |||
SNX20 | ENST00000300590.7 | c.171G>A | p.Thr57= | synonymous_variant | 3/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0146 AC: 2224AN: 152152Hom.: 59 Cov.: 32
GnomAD3 genomes
AF:
AC:
2224
AN:
152152
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00364 AC: 906AN: 249224Hom.: 19 AF XY: 0.00263 AC XY: 355AN XY: 134878
GnomAD3 exomes
AF:
AC:
906
AN:
249224
Hom.:
AF XY:
AC XY:
355
AN XY:
134878
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00142 AC: 2066AN: 1459846Hom.: 47 Cov.: 31 AF XY: 0.00123 AC XY: 891AN XY: 726316
GnomAD4 exome
AF:
AC:
2066
AN:
1459846
Hom.:
Cov.:
31
AF XY:
AC XY:
891
AN XY:
726316
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0147 AC: 2235AN: 152270Hom.: 59 Cov.: 32 AF XY: 0.0138 AC XY: 1024AN XY: 74456
GnomAD4 genome
AF:
AC:
2235
AN:
152270
Hom.:
Cov.:
32
AF XY:
AC XY:
1024
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at